Evaluation of WO2017098421: GSK’s benzothiazine compounds as CD73 inhibitor filings
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2018.1407756
Abstract: ABSTRACT Introduction: There are considerable interests in the development of novel small-molecule CD73 inhibitors for the treatment of cancers, autoimmune diseases, precancerous syndromes, and other diseases associated with CD73 activity. Areas covered: The application claims… read more here.
Keywords: benzothiazine compounds; gsk benzothiazine; wo2017098421 gsk; cd73 inhibitors ... See more keywords